ArticleMaterials today. Bio2026
A microenvironment-responsive injectable hydrogel with core-shell nanoplatforms for sequential treatment of infected bone defects.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The treatment of infected bone defects remains a major clinical challenge because conventional therapies have limited efficacy against biofilm-associated infections and fail to effectively promote subsequent bone regeneration. In this study, an injectable self-healing hydrogel incorporating core-shell nanoparticles (AMCG NPs) with photothermal, catalytic, and microenvironment-responsive properties was developed. The AMCG NPs consisted of gold nanorod cores and copper peroxide-loaded mesoporous polydopamine shells functionalized with glycol chitosan. In the acidic infectious microenvironment, AMCG NPs were rapidly released from the hydrogel and efficiently penetrated the biofilm through pH-dependent charge conversion. Under NIR-II irradiation, the nanoparticles disrupted biofilm integrity through the synergistic effects of mild photothermal therapy and acid-responsive catalytic activity. Transcriptomic analysis further revealed that AMCG + NIR treatment disrupted bacterial copper homeostasis and aggravated oxidative stress, resulting in membrane damage, lipid peroxidation, and tricarboxylic acid cycle dysfunction, thereby contributing to bacterial death. Following infection control, low concentrations of Cu
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.